RXRX Form 144: Director reports multiple Class A share sales

RXRX filed a Form 144 reporting proposed sales of Class A founder shares.

Rhea-AI Filing Summary

RXRX filed a Form 144 reporting proposed sales of Class A founder shares.

The filing lists four sales of 40,000 Class A shares on 01/05/2026, 01/20/2026, 02/04/2026, and 02/19/2026 with proceeds of $170,000, $178,800, $164,800, and $138,400, respectively.

Insights

Securities Compliance Analyst

Form 144 lists four discrete sales of Class A founder shares totaling 160,000 shares across January–February 2026.

The filing identifies four transactions of 40,000 Class A shares each on 01/05/2026, 01/20/2026, 02/04/2026, and 02/19/2026, with reported gross proceeds per trade shown in the filing.

These notices are procedural disclosures required under rule 144; cash‑flow treatment and whether sales were open‑market or private are not stated in the provided excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RXRX report in this Form 144?

The filing reports four proposed sales of 40,000 Class A shares each on specific dates in Jan–Feb 2026, with reported proceeds of $170,000, $178,800, $164,800, and $138,400.

Who is the reported seller in the RXRX Form 144?

The filing names Christopher C. Gibson as the address-associated reporting person linked to the Class A share sales on the listed dates. The excerpt does not specify any additional sellers or entities.

How many shares are involved in the RXRX filing?

The filing shows four transactions of 40,000 Class A shares each, totaling 160,000 shares across the listed dates in January and February 2026 as reported in the excerpt.

Do the Form 144 entries state how the shares were sold?

The excerpt lists sale dates, share counts, and proceeds but does not describe the method of sale; the form does not state whether transactions were open-market, block trades, or privately negotiated in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 10:49 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001856369
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RECURSION PHARMACEUTICALS, INC.
SEC File Number	001-40323
Address of Issuer	41S RIO GRANDE STREET SALT LAKE CITY UTAH 84101
Phone	(385) 269-0203
Name of Person for Whose Account the Securities are To Be Sold	Gibson Christopher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	40000	130000.00	521950663	03/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/01/2016	Founders Shares	Issuer			40000	09/01/2016	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	01/05/2026	40000	170000.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	01/20/2026	40000	178800.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	02/04/2026	40000	164800.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	02/19/2026	40000	138400.00

144: Remarks and Signature

Remarks
Date of Notice	03/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Christopher Gibson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)